APONTIS PHARMA AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.65 EUR | +1.29% |
|
+5.13% | +81.05% |
| Apr. 05 | Apontis Bags Distribution Deal with Novartis Unit for Two Asthma Medications | MT |
| Mar. 28 | Apontis Pharma AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Apontis Pharma AG
Price target over the last 5 years
History of analyst recommendation changes
7af5527d0be0f103db84626.9jg9cMDVsPzfpol1q68WW3lPYasIFtmux4nQFrH99Oc.nF5lCbCi-qqp8_9A89lkMTE2MclhQqHMnfuYR8OZnJGUcXMThbnKnanVwA~922339c1b2c8dc66c502be1fdc0f8613
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.54
EUR
Average target price
17.5
EUR
Spread / Average Target
+104.92%
High Price Target
20
EUR
Spread / Highest target
+134.19%
Low Price Target
16
EUR
Spread / Lowest Target
+87.35%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- APPH Stock
- Consensus Apontis Pharma AG
